Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.
Ridker
Paul M
PM
Center for Cardiovascular Disease Prevention and the Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, Mass 02115, USA. pridker@partners.org
Brown
Nancy J
NJ
Vaughan
Douglas E
DE
Harrison
David G
DG
Mehta
Jawahar L
JL
D000328:Adult; D001161:Arteriosclerosis / Q000175:diagnosis*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis; D006710:Homocysteine / Q000097:blood; D006801:Humans; D007249:Inflammation / Q000097:blood; D017270:Lipoprotein(a) / Q000097:blood; D009569:Nitric Oxide / Q000032:analysis; D018384:Oxidative Stress; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D013927:Thrombosis / Q000175:diagnosis*; D010959:Tissue Plasminogen Activator / Q000097:blood
D015415:Biomarkers; D017270:Lipoprotein(a); D017395:Plasminogen Activator Inhibitor 1; D006710:Homocysteine; D009569:Nitric Oxide; D002097:C-Reactive Protein; D010959:Tissue Plasminogen Activator